Experts think it may be premature to say if existing measures can curb future outbreaks. Read more at straitstimes.com. Read ...

In Brazil, researchers from the University of São Paulo (USP), the University of Brasília (UnB), and two startups in the city ...

By artificially infecting Aedes mosquitoes with a bacterium, researchers have been able to block transmission of the dengue virus in the lab. But a field-based pilot project is needed to further valid ...

There is no specific medicine for dengue yet. If ongoing Phase III trials yield positive results, an effective, affordable & ...

Serum Institute of India and DNDi collaborate to accelerate development of an affordable dengue monoclonal antibody treatment ...

Against this backdrop, the parallel spike in dengue cases comes as a double blow, claiming at least 30 lives so far this year ...

A compound called diterpene found in mandaçaia bee propolis kills Aedes aegypti larvae rapidly and offers potential for ...

Serum Institute and DNDi sign MoU to develop and scale a dengue monoclonal antibody vaccine with Phase 3 trials in India, ...

“Strong and sustained community vigilance against breeding and innovations like Project Wolbachia have helped to avert large outbreaks,” it added. In 2024, over 13,600 dengue cases were ...

SII partners with DNDi to develop affordable dengue treatment, aiming to save lives in LMICs and endemic countries.

SII and DNDi will develop a work plan to implement research and development, Phase 3 clinical trials, and access activities, ...

Both organisations will collaborate to create joint development plans for research, Phase III clinical trials, and market ...